0001179110-18-013901.txt : 20181214
0001179110-18-013901.hdr.sgml : 20181214
20181214174517
ACCESSION NUMBER: 0001179110-18-013901
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181212
FILED AS OF DATE: 20181214
DATE AS OF CHANGE: 20181214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knowlton Calvin H
CENTRAL INDEX KEY: 0001685833
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37888
FILM NUMBER: 181236526
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc.
CENTRAL INDEX KEY: 0001651561
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 465726437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
BUSINESS PHONE: 866-648-2767
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
4
1
edgar.xml
FORM 4 -
X0306
4
2018-12-12
0
0001651561
Tabula Rasa HealthCare, Inc.
TRHC
0001685833
Knowlton Calvin H
228 STRAWBRIDGE DRIVE
SUITE 100
MOORESTOWN
NJ
08057
1
1
0
0
Chief Executive Officer
Common Stock
2018-12-12
4
S
0
6439
75.79
D
853980
D
Common Stock
2018-12-12
4
S
0
1561
76.18
D
852419
D
Common Stock
836371
I
Held by spouse.
This sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 7, 2018.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $75.14 to $76.12, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnotes (2) and (3) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $76.14 to $76.20, inclusive.
The sales aggregated in Row 1 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein.
The sales aggregated in Row 2 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein.
/s/ Brian W. Adams, by Power of Attorney
2018-12-14